Immunome Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqCM:IMNM Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
16 Aug 24	BuyUS$97,608	Jean-Jacques Bienaime	Individual	7,000	US$13.94
21 May 24	BuyUS$1,388,072	Clay Siegall	Individual	100,000	US$13.91
21 May 24	BuyUS$27,140	Jean-Jacques Bienaime	Individual	2,000	US$13.57

Insider Buying: IMNM insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 46.1%.

Top 25 shareholders own 84.49% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
9.75%	T. Rowe Price Group, Inc.	5,899,714	US$67.8m	56.8%	0.01%
8.08%	Redmile Group, LLC	4,889,554	US$56.2m	0%	2.81%
6.96%	FMR LLC	4,210,943	US$48.4m	-7.14%	no data
6.58%	BlackRock, Inc.	3,981,782	US$45.8m	5.93%	no data
6.41%	EcoR1 Capital, LLC	3,879,415	US$44.6m	0%	1.51%
5.75%	Enavate Sciences	3,478,261	US$40.0m	0%	no data
5.23%	Janus Henderson Group plc	3,163,507	US$36.4m	106%	0.02%
5.18%	The Vanguard Group, Inc.	3,131,568	US$36.0m	7.2%	no data
3.91%	State Street Global Advisors, Inc.	2,364,234	US$27.2m	1,080%	no data
3.84%	Arsenal Bridge Venture II, LLC	2,323,650	US$26.7m	-3.76%	no data
2.83%	Marshall Wace LLP	1,713,325	US$19.7m	229%	0.03%
2.58%	MorphImmune, Inc.	1,558,353	US$17.9m	0%	no data
2%	Geode Capital Management, LLC	1,207,455	US$13.9m	13.6%	no data
1.82%	Opaleye Management Inc.	1,102,500	US$12.7m	0%	1.94%
1.77%	Michael Rapoport	1,071,172	US$12.3m	0%	no data
1.65%	Vestal Point Capital, LP	1,000,000	US$11.5m	0%	0.81%
1.53%	Woodline Partners LP	922,892	US$10.6m	-30%	0.1%
1.44%	Avidity Partners Management, L.P.	873,891	US$10.0m	0%	0.43%
1.21%	Victory Capital Management Inc.	730,785	US$8.4m	48.2%	0.01%
1.19%	Tang Capital Management, LLC	720,000	US$8.3m	0%	0.73%
1.13%	Brown Advisory Incorporated	682,200	US$7.8m	1.86%	0.01%
1.09%	Longboat Family Office, LLC	660,479	US$7.6m	0%	no data
1.08%	Sofinnova Investment, Inc.	655,680	US$7.5m	10.3%	0.48%
0.73%	Charles Schwab Investment Management, Inc.	442,477	US$5.1m	217%	no data
0.72%	Purnanand Sarma	435,315	US$5.0m	4,050%	no data